Septin 9 + panel – ColonAIQ
This test is done to screen for colorectal cancer by detecting abnormal DNA methylation patterns, including the SEPTIN9 gene, in the blood. These molecular changes can be associated with the presence of colorectal tumors. It is a non-invasive screening tool used to help identify individuals who may need further diagnostic evaluation such as colonoscopy.